Pyrrolotriazine inhibitors of kinases

Details Pyrrolotriazine inhibitors of kinases Pyrrolotriazine inhibitors of kinases

2006-01-03

2006-01-03

Berch, Mark L. (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S183000, C548S530000, C548S532000

Reexamination Certificate

active

06982265

ABSTRACT:
The present invention provides compounds of formula Iand pharmaceutically acceptable salts thereof.The formula I compounds inhibit the tyrosine kinase activity of growth factor receptors such as VEGFR-2, FGFR-1, PDGFR, HER-1, HER-2, thereby making them useful as anti-cancer agents. The formula I compounds are also useful for the treatment of other diseases associated with signal transduction pathways operating through growth factor receptors.

REFERENCES:
patent: 4908056 (1990-03-01), Tseng
patent: 5686457 (1997-11-01), Traxler et al.
patent: 6670357 (2003-12-01), Leftheris et al.
patent: 6787545 (2004-09-01), Ohtani et al.
patent: 6867300 (2005-03-01), Godfrey et al.
patent: 6869952 (2005-03-01), Bhide et al.
patent: 2003/0069244 (2003-04-01), Leftheris et al.
patent: 2005/0009823 (2005-01-01), Chen
patent: 2005/0043306 (2005-02-01), Leftheris et al.
patent: 778 277 (1997-06-01), None
patent: 0 795 556 (1997-09-01), None
patent: WO 98/08847 (1998-03-01), None
patent: WO 01/14378 (2001-03-01), None
Ewald H. et. al., “Reactionen von 1,2,4-Triazinen mit Acetylendicarbonsaure-dimethylester”. Justus Liebigs Annalen Der Chemie, (1977), vol. 10, pp. 1718-1724.
Migliara, J. Het. Chem 16, 833 (1979).
Otter et al, Nucleoside & Nucleotides, 15(1-3), 793-807 (1996).
Quintela et al, Tetrahedron, 52(8), 3037-3048 (1996) .
Patil et al, J. Heterocyclic Chem., 31(4), 781-807 (1994) .
Neunhoeffer et al, Justus Liebigs Ann. Chem., vol. 9, 1413-1420 (1977) & Chem. Abstr. 88:121113q, (Apr. 1978) .
Skobe et al, Nature Medicine, vol. 3, No. 11, 1223-1227 (Nov. 1997) .

Affiliated with

Also associated with

Rating

Pyrrolotriazine inhibitors of kinases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrrolotriazine inhibitors of kinases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolotriazine inhibitors of kinases will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3548635